More recently, subsets of CSCs (CD44+/CD24− and ALDH+) with varying EMT status (mesenchymal and hybrid E/M, respectively) have been described in breast cancers [123,166], with the mesenchymal subset located at the invasive edge and the hybrid E/M subset located in the tumor interior. Here, LDHA is linked to neoplasm.